Navigation Links
Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
Date:9/26/2007

COLORADO SPRINGS, Colo., Sept. 26 /PRNewswire-FirstCall/ -- Spectranetics Corporation (Nasdaq: SPNC) today announced it has enrolled the first patient in the PATENT trial utilizing the Company's TURBO elite(TM) laser catheters in combination with the recently FDA cleared TURBO-Booster(TM).

The PATENT trial is a prospective registry of 100 patients at up to 10 sites in Germany. The trial will assess patency as measured by duplex ultrasound at various intervals up to 12 months following the procedure. It will also assess safety as measured by adverse events up to 12 months following the procedure. In the initial procedure performed at the Leipzig Heart Center, four focal lesions were treated successfully with the TURBO-Booster and TURBO elite 2.0mm catheter in a 20cm long stented superficial femoral artery.

"The initial result from this Spectranetics device looks very promising, as the new features allow for ablation of more tissue in larger vessels," said Andrej Schmidt, M.D., of the University of Leipzig-Heart Center. "Instent restenosis in a superficial femoral artery represents one of the most challenging procedures in our practice. The current standard of care, such as repeat balloon angioplasty, does not have good results as these lesions tend to reoccur. We are very excited with the start of this study in Germany, and we look forward to examining the mid- and long-term results of this new therapy."

John G. Schulte, Spectranetics' President and Chief Executive Officer, commented, "We are very pleased to have begun this trial at one of Europe's most prestigious medical centers. We believe that instent restenosis in the superficial femoral artery may represent 25% to 35% of all above-the-knee proce
'/>"/>

SOURCE Spectranetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 2015  Omeros Corporation (NASDAQ: OMER ) today ... Par Pharmaceutical, Inc. and its subsidiary, Par Sterile Products, ... the District of New Jersey ... of Delaware . The lawsuits were ... three Omeros patents, U.S. Patent Nos. 8,173,707, 8,586,633 and ...
(Date:9/3/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/hs5hvr/investigation ) has ... on China Tamsulosin Market, 2010-2019" report to ... a1- adrenergic receptor blockers, tamsulosin hydrochloride developed by ... urinary tract infections and therefore is fitter for ... in Japan , tamsulosin hydrochloride ...
(Date:9/3/2015)... 2015 Pharma major Lupin ... Inc. (Lupin) has launched its Duloxetine 40 mg ... only generic Duloxetine formulation to become available in ... bring this new strength to market, as it ... greater flexibility of treatment.      (Photo: ...
Breaking Medicine Technology:Omeros Files Infringement Suits Against Par 2Omeros Files Infringement Suits Against Par 3Omeros Files Infringement Suits Against Par 4China Tamsulosin Market Investigation Report 2015 2Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 2Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 3Lupin Launches First-ever Duloxetine 40mg Delayed-Release Capsules in the US 4
... Be Useful in Cancer Treatment,Decisions , SALT LAKE ... (<a target="_blank" href=,"http://www.myriad.com/">www.myriad.com ) announced today that,it presented ... used to,determine the original location of a metastatic ... meeting of the American Association,for Cancer Research (AACR) ...
... WIRE)--Apr 19, 2007 - King,Pharmaceuticals, Inc. (NYSE:KG) ... results from the Phase III clinical trial,evaluating ... ALTACE(R),(ramipril) diuretic fixed-dose combination product. The Company ... expects to present the,findings in detail at ...
Cached Medicine Technology:Myriad Genetics Presents Tumor Origin Technology at AACR 2Myriad Genetics Presents Tumor Origin Technology at AACR 3King Pharmaceuticals Announces Plan to Report Positive Data from,Phase III Clinical Trial Evaluating the Combination of Altace with,Hydrochlorothiazide 2
(Date:9/3/2015)... ... September 03, 2015 , ... William Mattar Law Offices is known for ... does not stop at any certain demographic or segment of the population. Because ... fifteen- and ten-second TV commercials. , The closed captioning will allow people with hearing ...
(Date:9/3/2015)... Rhinebeck, NY (PRWEB) , ... September 03, 2015 ... ... Kitslaar when he made the company the final destination of his six-month, 10,000 ... , During the trek—which he calls the “Connecting Las Americas” ...
(Date:9/3/2015)... ... September 03, 2015 , ... Silverado next week ... 4400 Columbine Drive in Bellingham, Washington. Silverado Bellingham, a 41,000 square foot, single-story ... to serve up to 80 people living with Alzheimer’s, dementia and other memory-impairing ...
(Date:9/3/2015)... ... 03, 2015 , ... RealtyShares , the online marketplace ... investors to real estate investment opportunities nationwide, today announced that it is introducing ... and sponsoring real estate companies. , These products typically involve investors ...
(Date:9/3/2015)... ... September 03, 2015 , ... For the second ... Annual Inc. 5000 list of fastest-growing private companies in America. President and ... the nation's companies have demonstrated such remarkably consistent high growth, particularly in the ...
Breaking Medicine News(10 mins):Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:RealtyShares Announces Mezzanine Financing Products 2Health News:RealtyShares Announces Mezzanine Financing Products 3Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2
... and offer comment , , HARRISBURG, Pa., July 1 ... the Community Health Reinvestment Activities, also known and CHR, for ... plans are submitted to the Insurance Department by way of ... as Act 62 of 2008. , , Community ...
... study reports on posterior cruciate ligament treatment options, but investigation is not ... have been made in the understanding of posterior cruciate ligament ... July 2009 issue of the Journal of ... finds that there must be continued advances in basic science research in ...
... Grammy-winning rapper and award-winning actor Ice-T, known ... month,s episode of Sharing Miracles - a 30-minute ... stories of real patients. Sharing Miracles airs every ... , , One of the most controversial pioneers of ...
... , Dedicated to advancing scientific research in regenerative medicine ... of universities, life sciences companies, health care investors, and ... therapies united today to launch the Alliance for Regenerative ... Washington, DC, the Alliance is dedicated to promoting regulatory, ...
... XLHealth, owner of one of the nation,s largest Medicare ... improving the quality of care for seniors with chronic ... to serve as its vice president of contracting and ... for the establishment, strategic planning, and management for the ...
... 2009, 7 a.m. ET) Tufts dental researchers conducted a ... option for receding gums and found that complete root coverage ... This specific tissue regeneration application, developed at Tufts, reduces the ... case study of six patients is published in the July ...
Cached Medicine News:Health News:Insurance Department Seeks Comment On Community Health Reinvestment Activities 2Health News:The 'Other' Cruciate Ligament: Newer Treatments for PCL Tears 2Health News:The 'Other' Cruciate Ligament: Newer Treatments for PCL Tears 3Health News:'Sharing Miracles' Television Program to Feature Legendary Rapper and Popular Actor Ice-T 2Health News:'Sharing Miracles' Television Program to Feature Legendary Rapper and Popular Actor Ice-T 3Health News:'Sharing Miracles' Television Program to Feature Legendary Rapper and Popular Actor Ice-T 4Health News:'Sharing Miracles' Television Program to Feature Legendary Rapper and Popular Actor Ice-T 5Health News:'Sharing Miracles' Television Program to Feature Legendary Rapper and Popular Actor Ice-T 6Health News:'Sharing Miracles' Television Program to Feature Legendary Rapper and Popular Actor Ice-T 7Health News:'Sharing Miracles' Television Program to Feature Legendary Rapper and Popular Actor Ice-T 8Health News:Alliance for Regenerative Medicine Launches 2Health News:XLHealth Appoints New Vice President of Contracting and Provider Relations 2Health News:New treatment for receding gums: No pain, lots of gain 2Health News:New treatment for receding gums: No pain, lots of gain 3
... The Patient Pak contains ... four bars (can be separated ... and two grounds. Single patient ... lead wires (one twisted red ...
... system has been developed utilizing all ... motorsports. Our cool suit is simple ... from ice water circulated through an ... Systems can support from one to ...
... best, least expensive way to prevent hypothermia in ... degrees, eliminating the need for patient warming devices. ... surgical team some heat discomfort. The Cool Vest ... of OR temperatures. The lightweight, easy-to-use vest can ...
... new generation FilterWire EZ System has focused ... providing you with the confidence of greater ... ,The FilterWire EZ System adds predictability to ... technique. The filter loop provides protection ...
Medicine Products: